These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34763274)

  • 21. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
    Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Kelleher A; Collins P; Li J; Bush A; Shinebourne EA; Redington AN
    Circulation; 1999 Aug; 100(7):749-55. PubMed ID: 10449698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
    Alvarez J; Baluja A; Selas S; Otero P; Rial M; Veiras S; Caruezo V; Taboada M; Rodriguez I; Castroagudin J; Tome S; Rodriguez A; Rodriguez J
    Anaesth Intensive Care; 2013 Nov; 41(6):719-27. PubMed ID: 24180712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.
    Nijhawan N; Nicolosi AC; Montgomery MW; Aggarwal A; Pagel PS; Warltier DC
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):219-28. PubMed ID: 10445673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.
    Ricci Z; Garisto C; Favia I; Vitale V; Di Chiara L; Cogo PE
    Intensive Care Med; 2012 Jul; 38(7):1198-204. PubMed ID: 22527079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
    Bragadottir G; Redfors B; Ricksten SE
    Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.
    Lilleberg J; Nieminen MS; Akkila J; Heikkilä L; Kuitunen A; Lehtonen L; Verkkala K; Mattila S; Salmenperä M
    Eur Heart J; 1998 Apr; 19(4):660-8. PubMed ID: 9597417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
    Yan SB; Wang XY; Shang GK; Wang ZH; Deng QM; Song JW; Sai WW; Song M; Zhong M; Zhang W
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):149-160. PubMed ID: 31523760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful weaning from cardiopulmonary bypass after cardiac surgery using inhaled nitric oxide.
    Bichel T; Spahr-Schopfer I; Berner M; Jaeggi E; Velkovski Y; Friedli B; Kalangos A; Faidutti B; Rouge JC
    Paediatr Anaesth; 1997; 7(4):335-9. PubMed ID: 9243693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J; Taboada M; Rodríguez J; Caruezo V; Bouzada M; Campaña O; Bascuas B; Pérez-Paz J; Ginesta V
    Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan in Cardiac Surgery: Evaluating the Evidence.
    Faisal SA; Apatov DA; Ramakrishna H; Weiner MM
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1146-1158. PubMed ID: 30055988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery.
    Pan KC; Shankar S; Millar J; Chiletti R; Butt W; d'Udekem Y; Namachivayam SP
    Eur J Cardiothorac Surg; 2021 Jan; 59(1):262-268. PubMed ID: 32910173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
    Zangrillo A; Alvaro G; Belletti A; Pisano A; Brazzi L; Calabrò MG; Guarracino F; Bove T; Grigoryev EV; Monaco F; Boboshko VA; Likhvantsev VV; Scandroglio AM; Paternoster G; Lembo R; Frassoni S; Comis M; Pasyuga VV; Navalesi P; Lomivorotov VV;
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2152-2159. PubMed ID: 29580796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial.
    Thorlacius EM; Wåhlander H; Ojala T; Ylänen K; Keski-Nisula J; Synnergren M; Romlin BS; Ricksten SE; Castellheim A
    J Cardiothorac Vasc Anesth; 2020 Aug; 34(8):2072-2080. PubMed ID: 32201198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to nitric oxide during adult cardiac surgery.
    Solina AR; Ginsberg SH; Papp D; Pantin EJ; Denny J; Ghandivel I; Krause TJ
    J Invest Surg; 2002; 15(1):5-14. PubMed ID: 11931495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
    Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current role of total intravenous anesthesia in cardiac surgery: total intravenous anesthesia and cardiopulmonary bypass.
    Schraag S
    J Cardiothorac Vasc Anesth; 2015 Jun; 29 Suppl 1():S27-30. PubMed ID: 26025043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.